Hafrun Fridriksdottir

Insider Reports History

Entity
Individual
Location
400 Interpace Parkway, Parsippany, NJ
Signature
/s/ Dov Bergwerk as attorney-in-fact for Hafrun Fridriksdottir
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hafrun Fridriksdottir:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Executive VP, Global R&D Ordinary Shares 1.39K $13.5K $9.73 May 17, 2022 Direct

Insider Reports Filed by Hafrun Fridriksdottir

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD May 17, 2022 1 -$1.07M 4 May 19, 2022 Executive VP, Global R&D
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2022 10 -$250K 4 Mar 8, 2022 Executive VP, Global R&D
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 28, 2022 3 -$61.8K 4 Mar 2, 2022 Executive VP, Global R&D
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 8, 2022 4 -$55.4K 4 Feb 10, 2022 Executive VP, Global R&D
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 10, 2021 1 -$506K 4 Aug 12, 2021 Executive VP, Global R&D
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD May 11, 2021 3 -$195K 4 May 13, 2021 Executive VP, Global R&D